Should Day Traders Consider Elray Resources Inc(OTCMKTS:ELRA), Biocept Inc(NASDAQ:BIOC), and Asterias Biotherapeutics Inc(NYSEMKT:AST)?

Posted by Saimoon November 13, 2014 0 Comment 868 views


New York, NY – GDP INSIDER  –  11/13/2014.

This article discusses three companies: Elray Resources Inc(OTCMKTS:ELRA), Biocept Inc(NASDAQ:BIOC), and Asterias Biotherapeutics Inc(NYSEMKT:AST)

Elray Resources Inc(OTCMKTS:ELRA) is a Cambodia-based online gaming company that owns and operates SierraCasino.com, Knutspoker.com, and LuckyLucyBingo.com. The company filed a Form 8-K yesterday detailing LG Capital Fuding’s decision to convert its Convertible Promissory Notes “in the principal amount of $124,000 and accrued interest of $3,636 into shares.” Elray Resources had a trading volume of 132.78 million yesterday, a figure which is 19.37 million lower than its three month average.

Could Elray Resources Be A Buy-Low Candidate? View Our Free ELRA Analysis.

Biocept Inc(NASDAQ:BIOC) develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests. The California-based cancer diagnostics company offers the OncoCEE-BR breast cancer CTC test and the OncoCEE-LU lung cancer test. On Nov. 12th, the company announced that it had launched its lung cancer liquid biopsy testing, which will be performing at the company’s laboratory. Biocept has traded within a range of $2.27 to $10.03, yet finished yesterday’s trading at a closing price of $3.84 after a $1.10 gain.

Is Biocept A Strong Investment Option? Receive A Free BIOC Analysis.

Asterias Biotherapeutics Inc(NYSEMKT:AST) is a California-based development stage biotechnology company that develops therapeutic products that are used to treat neurology, oncology, cardiology, and blood and vascular diseases. The company is currently developing embryonic stem cell programs. Asterias Biotherapeutics announced its third quarter financial results on Nov. 10th, 2014. The figures included total revenue of $84,515 and an operating expenses figure of $4.0 million, which represents a $1.3 million year-over-year increase.

Should You Invest In Asterias Biotherapeutics? Click Here For A Free AST Analysis.

About HotStockGains

HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.

Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.


Write Your Comment